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Abstract
This study investigated the relationship between host efflux system of the non-vertebrate
nematode Caenorhabditis elegans and Burkholderia cepacia complex (Bcc) strain viru-
lence. This is the first comprehensive effort to profile host-transporters within the context of
Bcc infection. With this aim, two different toxicity tests were performed: a slow killing assay
that monitors mortality of the host by intestinal colonization and a fast killing assay that
assesses production of toxins. A Virulence Ranking scheme was defined, that expressed
the toxicity of the Bcc panel members, based on the percentage of surviving worms.
According to this ranking the 18 Bcc strains were divided in 4 distinct groups. Only the Cys-
tic Fibrosis isolated strains possessed profound nematode killing ability to accumulate in
worms’ intestines. For the transporter analysis a complete set of isogenic nematode single
Multidrug Resistance associated Protein (MRP) efflux mutants and a number of efflux inhibi-
tors were interrogated in the host toxicity assays. The Bcc pathogenicity profile of the 7 iso-
genic C. elegansMRP knock-out strains functionality was classified in two distinct groups.
Disabling host transporters enhanced nematode mortality more than 50% in 5 out of 7
mutants when compared to wild type. In particularmrp-2 was the most susceptible pheno-
type with increased mortality for 13 out 18 Bcc strains, whereasmrp-3 andmrp-4 knock-
outs had lower mortality rates, suggesting a different role in toxin-substrate recognition. The
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use of MRP efflux inhibitors in the assays resulted in substantially increased (>40% on aver-
age) mortality of wild-type worms.
Introduction
The Burkholderia cepacia complex (Bcc) occupies a critical position among Gram-negative
multi-drug resistant bacteria. It consists of at least 20 closely related species inhabiting different
ecological niches, including plants and animals [1–5]. Bcc multi drug and pandrug-resistant
opportunistic human pathogens cause problematic lung infections in immune-compromised
individuals, including cystic fibrosis (CF) patients [6–8]. Bcc members are naturally resistant
to antibiotics including cephalosporins, β-lactams, polymyxins and aminoglycosides, rendering
Bcc infections challenging to eradicate [9,10]. There is an imminent need to develop new Bcc
antimicrobial therapeutic strategies. Dissecting virulence and pathogenicity determinants as
well as identifying novel therapeutic targets may be promising approaches. These tasks may be
advanced by the exploitation of the non-vertebrate host models Drosophila melanogaster, Gal-
leria mellonella, and Caenorhabditis elegans. Model hosts have been used to evaluate microbial
virulence traits involved in mammalian infections and the efficacy of antimicrobial compounds
[11–16]. The free-living nematode C. elegans is a widespread multicellular organism that is a
self-fertilizing hermaphrodite with a rapid generation time. C. elegans has been proven cost-
effective, ethical, reproducible and genetically powerful infection model despite the obvious
reported technical limitations (nematodes have lower optimal growth temperatures when com-
pared with human pathogens; occurrence of host specific virulence factors) [15,17–19]. In fact,
there is an extensive body of literature for the utility of the nematode to model infection with a
variety of Gram-negative bacteria including Escherichia coli, Burkholderia pseudomallei, B.
cepacia complex and Pseudomonas aeruginosa [20–23]. The C. elegans-Bcc studies in the last
decade have shed some light on the complex-nematode interaction, correlating genotypic char-
acteristics of the pathogen with phenotypic changes in the host. These efforts have identified
specific virulence factors: the auto inducer dependent Acyl-HomeSerineLactone (aidA), the
phenazine biosynthesis regulator (Pbr), and the host factor phage Q, (hfq) [16,24–33].
Recent studies have underlined the importance of efflux systems in infection within the con-
tent of host-pathogen interaction [34–36]. The host efflux capability is considered part of a
basic defence mechanism. For example the B. pseudomallei infection stimulates the overpro-
duction of the ATP Binding Cassette (ABC) transporter pgp-5 in C. elegans [37]. However, the
partition of host transporters in the infection process has never been studied in depth. Bcc
members produce a variety of metabolites and toxins, potential host efflux substrates. Further-
more, exploring the role of host transporters in pathogenicity may facilitate the design of
appropriate tools for toxin identification. Multidrug Resistance associated Proteins (MRPs) are
members of the ABC efflux transporter family with broad substrate specificity for the transport
of endogenous and xenobiotic anionic substances found in Bacteria, Archaea and Eukarya [38–
41]. MRPs play important roles in nematode physiology such as control resistance to anthel-
mintic (ivermectine) and heavy metals (arsenic) [42–44]. This study emphasizes the contribu-
tion of the host MRP efflux subfamily to Bcc virulence, employing a panel of 18 strains
representing the up-to-date different acknowledged species and a fully functional seven single
C. elegansmutant set impaired in MRPs. A Virulence-Ranking (VR) scheme based on compar-
ing host survival rates in two different assays was developed. This scheme provides the tool for
a detailed study on the effect of the MRP transporter family on Bcc virulence using as well as
selected efflux inhibitors.
Role of MRPs in Bcc Pathogenicity UsingC. elegans as Infection Model
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Materials and Methods
Bacterial strains, nematode strains and growth conditions
C. elegansWild-type (WT) Bristol N2, NL147 (mrp-1(pk89) X), RB1713 (mrp-2(ok2157) X),
RB1028 (mrp-3(ok955) X), VC712 (mrp-4(ok1095) X), VC1599 (mrp-5(ok2067)/szT1 X),
RB1070 (mrp-6(ok1027) X) and RB1269 (mrp-8(ok1360) III) strains were obtained from the
Caenorhabditis Genetic Centre (CGC). For strain VC1599, due to ok2067mutation lethality
in homozygosis, all the experiments were performed assaying heterozygotes worms. All
mutants presented identical phenotypic traits in respect to WT: normal larval development
(eggs reaching adults state in 72 h as indicated on standard table (www.wormbook.org)),
non-impaired reproduction, and survival rate at 100% when fed with E. coli. Mutant mpr-5
in heterozygosis also aligned to those parameters. All strains were recovered from frozen
stocks, and routinely kept on NGM (Nematode Growth Medium) plates seeded with E. coli
OP50 as a food source [45]. The panel of Bcc strains used in this work belongs to the Bcc col-
lection at the University of Gent, Belgium, and is listed in Table 1. Bcc and E. coli OP50 cells
were routinely grown in Luria-Bertani broth (LB) (10 g/L Bacto-tryptone, 5 g/L Yeast extract,
10 g/L NaCl) at 37°C.
Nematode Toxicity Assays
Slow Killing Assay (SKA) was performed against the C. elegansWT strain N and MRP-
mutants. 2.5-cm-diameter plates containing 3 ml of NGM agar (Peptone 2.5 g/L, NaCl 2,9 g/L,
Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4 25 mM, MgSO4 1 mM) were
seeded with 50 μl of the overnight Bcc cultures, normalized to an OD600, of 1.7 and incubated
for 24 h at 37°C to allow the formation of a bacterial lawn. This was the standard bacterial
growth condition unless otherwise stated. C. elegansWT strain and MRP-mutants were syn-
chronized by bleaching treatment [46], and 30–40 worms at larval stage 4 (L4), were trans-
ferred to each plate and incubated at 20°C for three days. The plates were scored for living
worms every 24 h.
Fast Killing assay (FKA) was carried out in 2.5-cm-diameter plates containing 3 ml of
Peptone Glucose Sorbitol (PGS) agar medium [25] (Peptone 12 g/L, Glucose 12 g/L, Sorbitol
27.25 g/L, NaCl 12 g/L, Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4
25 mM, MgSO4 1 mM). Plates were prepared as described above for the SKA. Then, L4
worms fromWT strain and MRP-mutants were collected from NGM plates, washed with M9
medium (Na2HPO47H2O 12.8 g/L, Na2HPO4 (anhydrous) 6 g/L, KH2PO4 3 g/L, NaCl
0.5 g/L, NH4Cl 1 g/L) and 30–40 L4 worms were spotted onto the bacterial lawn. The plates
were then incubated at 20°C and scored for living worms every 24 h. In both assays, E. coli
OP50 was used as a negative control. A worm was considered dead when it no longer
responded to touch. For statistical purposes, 5 replicates per trial were carried out with a
unique egg preparation. The incubation time was set at 2 days. A pathogenicity scheme (VR)
was established by comparing the "infectivity" towards nematodes between E. coli OP50 and
Bcc isolates.
Microscopy analysis
40–60 WT L4 worms were grown on NGM plates seeded with Bcc or E. coli OP50 propagated
in standard growth conditions. Plates were incubated at 20°C, and after 4 and 24 h, the nema-
todes were inspected using a Zeiss Axioskop microscope equipped with Differential Interfer-
ence Contrast (DIC) employing 10x, 20x, 40x, 63x and 100x objectives and 10X eyepiece.
Images were collected with a Zeiss Axiocam MR digital camera.
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Toxin Diffusion assay
Bcc or E. coli OP50 cells were grown under standard growth conditions and spread on sterile
0.22 μmMillipore Nitrocellulose (Darmstadt, Germany) filter disk located onto 2.5-cm-diame-
ter PGS plates [25]. After overnight incubation at 37°C, the filter together with the bacterial
lawn was removed and the plates were allowed to cool to room temperature. 30–40 hypochlo-
rite-synchronised WT L4 nematodes were spotted onto the conditioned agar. Paralysation and
Table 1. Burkholderia cepacia complex used in this work and VR relative to the different killing assays.
Species Strain Source SKA FKA
Burkholderia cepacia LMG 1222 Onion 0 3
Burkholderia multivorans LMG
13010
CF 0 0
Burkholderia cenocepacia LMG
16656
CF 2 2
Burkholderia stabilis LMG
14294
CF 3 3
Burkholderia vietnamiensis LMG
10929
Soil 1 0
Burkholderia dolosa LMG
18943
CF 0 1
Burkholderia ambifaria LMG
19182
Soil 0 3
Burkholderia anthina LMG
20980
Soil 2 1
Burkholderia pyrrocinia LMG
14191
Soil 0 2
Burkholderia ubonensis LMG
20358
Soil 2 1
Burkholderia latens LMG
24064
CF 1 1
Burkholderia diffusa LMG
24065
CF 2 2
Burkholderia arboris LMG
24066
Soil 1 1
Burkholderia seminalis LMG
24067
CF 2 2
Burkholderia metallica LMG
24068
CF 3 3
Burkholderia lata LMG
22485
Soil 0 1
Burkholderia contaminans LMG
23361
AI 1 3
Burkholderia
pseudomultivorans
LMG
26883
CF 0 1
Abbreviations: Soil = Soil rhizosphere, AI = Animal Infections, CF = Cystic Fibrosis patients
VRs
0 = 100% > Survival worms > 80%
1 = 79% > Survival worms > 50%
2 = 49% > Survival worms > 6%
3 = 5% > Survival worms > 0%
doi:10.1371/journal.pone.0142883.t001
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mortality of the worms were detected at 4 and 24 h. The experiments were performed in tripli-
cate, and data reported are mean values ± SD.
Statistical analysis and clustering
All the Kaplan-Meier survival curves were analyzed using the Graph-pad Prism 5 software.
Comparisons vs. control for both the C. elegans and inhibitor experiments were performed
using Fisher’s exact test to account for possible non-Normality in the data. In particular, as it
was observed that replicate means of C. elegans percent mortality correlated extremely well to
pooled percent mortality (R2> 0.99 in all cases), counts of C. elegans that were alive and dead
after 72 h were used to populate the various 2x2 tables onto which the Fisher’s exact test was
applied. Bonferroni-Holm correction of p-values was used to account for the multiple compari-
sons performed.
Mutant clustering analysis was performed using hierarchical clustering via Ward’s method.
Clusters were fixed using a consistency threshold of 1.1, resulting in cophenetic coefficient
(correlation between cluster and metric distance) of at least 0.80.
Transporter Inhibitor assays
The MRP transporter inhibitors mometasone furoate, lasalocid A sodium, verapamil hydro-
chloride were purchased from Sigma-Aldrich, Saint Louis, MO. Compounds were dissolved in
DMSO and spread onto NGM plates in different concentration ranges: 25–100 μM (mometa-
sone and verapamil) and 125–500 nM (lasalocid). DMSO (0,5% w/v) was used as control. Sub-
sequently, Bcc strains (grown in standard conditions) were spotted onto the plates that were
incubated overnight at 37°C. After the incubation 30–40 WT L4 worms were spotted onto the
bacterial lawn. The plates were then incubated at 20°C for 3 days and scored for living worms
every 24 h. The experiments were performed in triplicate, and the data reported are mean
values.
Results and Discussion
Killing of C. elegans by Bcc strains
To evaluate Bcc virulence determinants and properties, two different assays were performed: i)
SKA, performed on a low osmolarity medium (NGM), assigned to correlate worms mortality
with intestinal bacterial accumulation/colonisation [24,25]; ii) FKA carried out on a high
osmolarity medium (PGS) to demonstrate the secretion of bacterial toxins and evaluate their
capacity to paralyse and kill the nematodes [24,25]. A VR was established for the Bcc strains
under investigation by comparing the "infectivity" against nematodes between E. coliOP50 and
Bcc isolates. The VR ranges from 0 to 3 (see Fig 1) and was based on the percentage of surviv-
ing worms after the period of observation, which was set at 3 days. A Bcc strain was considered
to be non-pathogenic (VR = 0) when no symptom of disease was observed during the course of
nematodes infection and the percentage of live worms at the conclusion of the period of obser-
vation ranged from 100 to 80%; VR = 1 corresponded to a percentage of alive worms between
79 to 50%; VR = 2 corresponded to a percentage of alive worms between 49 to 6%; finally, the
VR was considered 3 when the percentage of surviving worms was 5%.
SKA performed against WT L4 worms revealed diverse pathogenicity capabilities among
the 18 Bcc representatives [Table 1]:
i. 2 Bcc strains (B.metallica, B. stabilis) displayed high nematocide activity (VR 3). No viable
nematodes were detectable in the plates after 3 days of incubation at 20°C.
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ii. Half of the Bcc strains exhibited VR between 1 and 2, showing an intermediate toxicity
towards C. elegans.
iii. Seven Bcc strains (B. ambifaria, B. cepacia, B. dolosa, B. pseudomultivorans, B. pyrrocinia,
B. lata and B.multivorans) were unable to kill worms, and the whole population was viable
(VR = 0).
Nematodes killed in the lawn of bacteria took on a ghostly and hollow “shell-like” appear-
ance about 48 h after the L4 were first introduced, and their shells induced by B. ubonensis, B.
metallica and B. stabilis were defined as “chalk-mark ghosts”. This shape is characteristic of
organisms lacking a discernible internal cell structures. Often the ghosts eroded to a mere
outline.
The pathogenicity of the 18 Bcc strains was then assessed on FKA. Data obtained are sum-
marised in Table 1. Nematodes death on FKA appeared to be a rapid process as they loose
locomotor functions, as shown by the quick onset of lethargy. Motility visibly decreased after
exposure for 4 h, and the rate of foraging was similarly affected in the same time frame. In
FKA, five strains (B. ambifaria, B. cepacia, B. contaminans, B.metallica, B. stabilis) demon-
strated deep killing ability (VR = 3) against C. elegans and only two strains (B.multivorans and
B. vietnamiensis) were completely ineffective in killing worms. For the highly active strains,
almost 100% mortality occurred in 24 h, while on SKA 3 days are required for complete killing
(Fig 2).
Nine out of 18 Bcc strains have previously been characterized using SKA [30,47]. The VR of
7 strains (B. anthina, B. ubonensis, B. vietnamiensis, B. cenocepacia B. dolosa B. ambifaria, B.
cepacia) are consistent with the previously reported SKA ranking. The same comparison
revealed a variation for B. pyrrocinia and B. stabilis, which were found as more and less
Fig 1. Kaplan-Meier survival plots for L4 N2 worms fed with exemplifying Bcc strains for different VR grown on PGSmedium.Worms fed on: B.
metallica (VR 3; black line; n = 113; 0% survival at day 2); B. seminalis (VR 2; blue line; n = 150; 34% survival at day 2); B. dolosa (VR 1; redline; n = 198; 69%
survival at day 2); B.multivorans (VR 0; green line; n = 120; 93% survival worms). n: Number of worms at day 0. All p-values, comparing each survival curve
between them, resulted to be < 0.0001, calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
doi:10.1371/journal.pone.0142883.g001
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virulent, respectively. This variability may be due to ranking differences, as the experimental
conditions were very reproducible. This is the first report for an indicative pathogenicity rank-
ing for 8 Burkholderia species, recently added to Bcc, (B. latens, B. diffusa, B. arboris, B. semina-
lis, B.metallica, B. pseudomultivorans, B. lata, B. contaminans). B.metallica, B. stabilis (both
isolated from CF patients) were the most virulent in both assays (Fig 2B and 2C). The compar-
ison of data obtained in the FKA and SKA revealed that, on average, strains isolated from CF
patients appeared more virulent than environmental isolates on SKA. In particular, three Bcc
strains (B. ambifaria, B. cepacia and B. pyrrocinia) exhibited high nematocide activity in the
FKA, whereas they were unable to kill the worms in the SKA (VR 0 and 1). Therefore we can
assume that toxin production is a common virulence mechanism for Bcc members, while CF
isolates might have acquired different pathogenic traits that allow them to infect and colonize
hosts, as already proposed by Pirone et al. [48]. The only exception is represented by B.multi-
vorans, and B. pseudomultivorans. These two strains are CF isolates, but were non-virulent
towards nematodes. This evidence likely rely in the limitation of the nematode host model,
once more indicating that virulence factors are not universal for all hosts [15].
Bacterial intestinal accumulation. The two Bcc strains with VR = 3 in the SKA (B. stabilis
and B.metallica) were then assessed for their ability to accumulate in the C. elegans intestine.
Worms grown in standard condition were inspected using a compound microscope at different
incubation times to evaluate the bacterial accumulation in the intestinal lumen.
Bcc colonization of nematode occurred rapidly. After 4 h of incubation, worms fed with E.
coli OP50 showed a thin intestinal lumen (Fig 3A and 3B), whereas, when spotted onto B.
metallica layer, worms already presented deformed intestines (Fig 3E). After 24 h nematodes
displayed a full intestinal lumen packed with bacteria (Fig 3F). These data confirmed that Bcc
with high VR were able to accumulate within the entire nematode intestine and therefore slow-
killing may resemble an infection-like process. On the contrary, nematodes exposed to the
strain B. pseudomultivorans, which exhibited a low pathogenicity (VR = 0 on SKA), under the
same experimental conditions presented a healthy intestine with the presence of bacterial cells
only in the first part of the intestine (Fig 3C and 3D). This finding may signify that: i) even
non-pathogenic Bcc strains were able to pass intact through the pharynx and occupy the
Fig 2. Kaplan-Meier survival plots for L4 stageWTworms fed with: E. coli OP50 (solid lines), Bcc strains on NGM (dashed lines), Bcc strains on
PGS (dotted lines). n: Number of worms at day 0. A) The pathogenicity of Bcc strain B. cepacia on SKA (n = 93) was compared with the ability on FKA
(n = 184). B) The pathogenicity of Bcc strain B.metallica on SKA (n = 80) was compared with the ability on FKA (n = 113).C) The pathogenicity of Bcc strain
B. stabilis on SKA (n = 87) was compared with the ability on FKA (n = 161). P-values were calculated between survival curves on FKA and SKA of each
bacteria, and resulted to be < 0.0001 calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
doi:10.1371/journal.pone.0142883.g002
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Fig 3. The ability of Bcc strains to accumulate inC. elegans intestinal lumen was evaluated with microscopy analysis. Red arrows indicate the
nematodes intestine.A) Intestinal lumen of one L4 stageWT worm after 4 h of incubation on NGM plate spotted with E. coliOP50, andB) after 24 h of
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intestine; ii) the accumulation of the Bcc in the whole nematode gut, especially in the last part
of the intestine, might be responsible for the worm’s death [24].
Toxin Diffusion assay. To evaluate the contribution of diffusible secreted factors (toxins
and/or other virulence chemical signalling molecules) to the rapid kinetics of killing on FKA,
we performed the toxin diffusion assay [25]. These experiments were carried out on a reduced
panel consisting of the five Bcc strains possessing the highest nematocide activity on FKA (B.
contaminans, B. cepacia, B. ambifaria, B.metallica and B. stabilis). Results shown in Fig 4
revealed that a high percentage of worms were paralyzed after 4 h of incubation on plates, even
if they were not in contact with the bacteria. In particular, only 30% of the worms placed on B.
ambifaria plates were still mobile and active, whereas the remaining nematode population
appeared paralysed. On the contrary, worms spotted on plates containing E. coli conditioned
agar did not present any paralysis or mortality. Among the tested Bcc strains, B. ambifaria was
the most active toxin producer. Indeed, after 24 h of incubation only 20% of the total number
of nematodes was still moving on B. ambifaria plates (Fig 4). In the case of B. stabilis, it was
observed that paralyzed worms at 4 h were able to move again and survive. One plausible
explanation for this variation might be related to low stability of the diffusible toxins/virulence
determinants produced by those strains that require constant production.
Interestingly, when the toxin filter assay was performed on NGMmedium, no paralysis or
mortality was detected. This experiment confirms that FKA rapid killing kinetics revealed a
role for diffusible toxins as a main component of the infectious process. Thomson and Dennis
demonstrated the production by Bcc strains of a haemolytic toxin required for full virulence,
synthesized by a non-ribosomal peptide synthase (NRPS) pathway, typical of a complex sec-
ondary metabolite [49]. They screened a panel of Bcc strains including B. cenocepacia, B. stabi-
lis, B. pyrrocinia and B. vietnamiensis for the presence of this gene cluster. A NRPS cluster was
identified in B. pyrrocinia and B. stabilis with VR = 3 on FKA. Moreover, Bcc strains are
known to produce toxins with demonstrated antifungal activity like the cyclic peptides occidio-
fungins (burkholdines) [50]. Therefore, we cannot a priori exclude the possibility that a peptide
might represent the toxin active towards C. elegans.
Killing of MRPs knock-out C. elegansmutants by Bcc member strains
The nematode-Bcc pathogenicity ranking system developed was investigated for its ability to
detect and map genotype-specific host responses. We obtained access to a complete, seven
MRPs knock-out nematode mutant set,mrp-1(pk89),mrp-2(ok2157),mrp-3(ok955),mrp-4
(ok1095),mrp-5(ok2067),mrp-6(ok1027) andmrp-8(ok1360), impaired in the corresponding
ABC membrane transporters.
These knock-out mutants exhibited identical phenotypic attributes with the WT. The 18
Bcc representative strains were profiled against the 7 mutants in both SKA and FKA. Control
mortality was calculated to be the number of dead worms divided by the number of total
worms. Pooled mortality counts (alive vs. dead) for each mutant were tested against the WT
using Fisher’s Exact test. Statistically significant (Bonferroni-Holm corrected p-value< 0.05)
differences fromWT are shown in Table 2. The mortality rates calculated were highly variable
suggesting a Bcc strain-specific effect towards the MRP C. elegansmutants. Some trends were
detected:mrp-5 andmrp-2 had increased mortality rate for several Bcc strains in both SKA and
incubation on the same plate.C) Intestinal lumen of one L4WT after 4 h of incubation on NGM plate spotted with B. pseudomultivorans (VR 0 on SKA, andD)
after 24 h of incubation on the same plate. E) Intestinal lumen of one L4WT after 4 h of incubation on NGM plate spotted with B.metallica (VR 3 on SKA, and
F) after 24 h of incubation on the same plate.
doi:10.1371/journal.pone.0142883.g003
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FKA. Specifically, 8 Bcc strains in SKA and 9 in FKA showed increased killing towardsmrp-5,
while 8 strains in SKA and 8 in FKA appeared more virulent againstmrp-2. C. elegansmutants
mrp-3 andmrp-4 displayed lower killing rates when incubated with several Bcc strains. In par-
ticular, mutantmrp-4 exhibited decreased mortality to 8 Bcc species in SKA and to 7 strains in
FKA. Regarding the Bcc strains, on SKA B. ambifaria displayed increased virulence towards
the whole mutant set, with mortality rate compared to the WT higher than 75% and 71%
towards,mrp-5 and mrp-6 respectively. B. arboris demonstrated an increased pathogenic effect
towardsmrp-1,mrp-2,mrp-6,mrp-8, while B. dolosa was more lethal againstmrp-2,mrp-5,
mrp-6,mrp-8mutants. On FKA, B. lata and B.multivorans were the most pathogenic strains
with increased mortality rate against all mutants, while B. diffusa was more virulent against 6
mutants, and B. arboris against 5 mutants.
The complete set of killing results for each Bcc strain generated a unique killing profile in
each MRP mutant. To determine whether these profiles constitute a coherent mutant classifica-
tion pattern, a hierarchical clustering of significant effect sizes vs. each strain (Ward’s method,
Consistency Threshold 1.1) was performed. This analysis showed different patterns formrp-3
andmrp-4 when compared with the rest of MRP-phenotypes in both FKA and SKA. However,
mrp-3 andmrp-4 share low sequence identity/similarity among them (data not shown), sug-
gesting that these two transporters do not have similar substrate specificity or function. These
MRP-phenotypes were grouped consistently and differentiated from the rest of single knock
out strains (Fig 5). This pattern could justify the diverse phenotypic response to Bcc of the
MRP knock-out mutants, indicating variation in substrate profile specificity for the 7 MRP
efflux systems. The clustering patterns of the other transporters suggest distinct substrate speci-
ficity, in agreement with the low degree of sequence identity/similarity shared among them
(data not shown). Nevertheless, we can assume that toxins and small molecules are MRP-
related substrates, and these transporters play a fundamental role in Bcc defence, with the
exception ofmrp-3 andmpr-4.
Fig 4. Secreted compounds or toxins mediate fast killing.Data reports paralysis and mortality at 4 and 24 h of worms plated on PGSmedium plates
treated with Bcc strains or E. coli grown on a sterile disk. Data represent mean values of three independent experiments and SD values are reported. P-
values were calculated between sample (Bcc) and control (OP50) at the corresponding time, and were always < 0.05.
doi:10.1371/journal.pone.0142883.g004
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Inhibitor experiments
The Bcc pathogenicity ranking system was used to facilitate testing for a distinct MRP-efflux
system substrate profile within the content of infection. Disabling efflux pumps genetically
Table 2. MRP knock-out C. elegansmutants mortality expressed as percentage of dead worms and comparison between the mutants and theWT.
Mutant mrp-5 was tested as heterozygote, due to lethality of the mutation in homozygosis. Statistical significant differences appear highlighted, with negative
values indicating statistically significant reductions in mortality fromWT, and with positive values indicating statistically significant increases in mortality from
WT.
Significant Changes in % Mortality
Strain WT Mortality FKA mrp-1 mrp-2 mrp-3 mrp-4 mrp-5 mrp-6 mrp-8
B. ambifaria 95 NS -27 NS NS NS NS NS
B. anthina 42 45 50 NS NS 58 NS NS
B. arboris 28 70 72 21 NS NS 72 72
B. cenocepacia 64 NS 31 NS -45 NS 27 NS
B. cepacia 100 -19 NS NS -19 NS -15 -18
B. contaminans 94 NS NS -17 -16 NS NS NS
B. diffusa 69 NS NS NS NS NS NS -26
B. dolosa 31 33 NS 59 NS 48 49 NS
B. latens 42 NS NS -34 NS 38 NS -28
B. metallica 100 NS NS -13 -17 NS NS -10
B. pseudomultivorans 20 NS NS NS NS 50 NS NS
B. pyrrocinia 70 NS 21 -44 -35 26 NS 29
B. seminalis 64 NS NS -44 -31 NS NS NS
B. stabilis 100 -9 -47 NS NS -10 -63% -77%
B. ubonensis 52 NS 41 NS -24% 38 NS 32
B. vietnamiensis 14 NS 40 -12% NS 57 61 35
B. lata 18 38 64 27 42 70 54 53
B. multivorans 7 33 22 21 34 62 28 45
Strain WT Mortality SKA mrp-1 mrp-2 mrp-3 mrp-4 mrp-5 mrp-6 mrp-8
B. ambifaria 6 61 67 30 28 75 71 58
B. anthina 91 9 NS -27 -24 NS NS NS
B. arboris 46 53 54 -35 NS NS 50 51
B. cenocepacia 81 NS NS NS -77 -65 -24 -54
B. cepacia 9 81 75 NS NS 78 62 45
B. contaminans 47 30 26 49 NS NS NS NS
B. diffusa 88 NS NS NS -25 NS NS NS
B. dolosa 13 NS 25 NS NS 61 61 28
B. latens 22 NS 43 -19 -19 46 NS 42
B. metallica 100 NS NS -14% -8% NS NS NS
B. pseudomultivorans 11 NS NS NS NS 30 NS NS
B. pyrrocinia 5 53 61 NS NS 64 57 46
B. seminalis 69 28 NS -50 -67 NS NS NS
B. stabilis 100 -90 -58 NS NS -55 -60 -84
B. ubonensis 83 -60 NS -28 -36 NS NS NS
B. vietnamiensis 46 -44 -39 -43 -44 -34 50 -41
B. lata 10 NS NS NS NS 52 NS NS
B. multivorans 3 NS 22 NS NS 35 41 NS
NS = Not significant difference
doi:10.1371/journal.pone.0142883.t002
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(knock-outs) or chemically (small molecules-inhibitors) should have a similar toll on increas-
ing nematode mortality. A pilot analysis was performed utilizing the Bcc strains that exhibited
increased C. elegans susceptibility in numerous efflux knock-outs on SKA (B. ambifaria, B.
arboris, B. cepacia, B. dolosa, B. pyrrocinia) and the well-characterized mammalian MRP-efflux
inhibitors mometasone furoate, lasalocid A and verapamil [51]. All compounds did not affect
Bcc or C. elegans viability at the concentration used for the assay, (S1 Fig) The compounds
were spread in concentration ranges onto NGM plates to perform SKA and DMSO (0.5%) was
used as a growth control. Control mortality was calculated to be the number of dead worms
divided by the number of total worms. Comparison to solvent control of pooled mortality
counts was done using Fisher’s Exact test; results were considered significant if Bonferroni-
Holm corrected p-values were less than 0.05. Statistically significant differences from the WT
are shown in Table 3. Reduction in mortality from the controls was not observed. The inhibitor
use in the infection system, provided a statistically significant increase of mortality in the pres-
ence of at least one inhibitor compared to DMSO controls for 3 Bcc strains, whereas B. pyrroci-
nia and B. ambifaria killing rates were not affected.
In particular, the presence of mometasone (100 μM), B. arboris, B. cepacia and B. dolosa
enhanced virulence against nematodes with mortality rate of 40% higher than the control.
Lasalocid (500 nM) caused an increase in the percentage of dead worms of 34% and 48%
Fig 5. Hierarchical Clusterings.Ward’s method with a consistency threshold 1.1 used to cluster mutants based on significant changes in pathogenicity.
doi:10.1371/journal.pone.0142883.g005
Table 3. Effect of ABC inhibitors duringC. elegans- Bcc infection on SKA. Nematodes mortality expressed as percentage of dead worms and com-
pared between samples with inhibitors and control with DMSO (0,5%). Statistical significant differences were reported.
Significant Changes in % Mortality
Strain Control Mortality Verapamil Mometasone Lasalocid
100 μM 50 μM 25 μM 100 μM 50 μM 25 μM 500 nM 250 nM 125 nM
B. cepacia 17 NS NS NS 45 NS NS 34 NS NS
B. arboris 20 35 NS 27 45 NS NS NS NS NS
B. dolosa 32 NS NS NS 44 29 NS 48 38 NS
NS = Not significant difference
doi:10.1371/journal.pone.0142883.t003
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with B. cepacia and B. dolosa, respectively. Verapamil (100 μM) enhanced killing only for B.
arboris, with a killing rate of 35% higher than the control. These results demonstrated that
the inhibitor driven MRP transporter inactivation results in increased mortality at least for
two inhibitors, of the nematodes to Bcc strains, supporting the role of these transporters in
Bcc infection. Verapamil has been characterized as a competitive inhibitor in ABCB1 malig-
nant cell overexpression [52] as wells as a potent ABCC family inhibitor [53]. It is also
involved in inhibiting C. elegans P-gp1, which is involved in nematode resistance to ivermec-
tine [54]. The present experimental setup differs as it explores verapamil against a number of
targets simultaneously not by isolating transporters of interest. This analysis suggests that
verapamil very likely works, but the number of interactions leading to a weaker phenotype
should be investigated further.
Conclusions
The major aim of this work was to inquire the role of host transporters in the infection devel-
oping a nematode virulence ranking system focusing in well-recognized Bcc strains. It is com-
mon knowledge that every bacterial species includes member-strains with different pathogenic
characteristics. However, the key purpose was to build the model using type strains of each of
the 18 currently known Bcc species, a combination of two different killing assays (SKA and
FKA), and a set of nematode mutants impaired in MRP efflux transporters. We focused on
type strains due to the extensive information known, as many Bcc genomes have been
completely sequenced and more will be soon become available. To define Bcc virulence we
established a VR scheme, based on the percentage of surviving worms. Both nematocidal assays
revealed different pathogenicity profiles for the Bcc species. Strains with high score in the VR
system were able to accumulate in the nematodes intestine and produce virulence factors, on
SKA and FKA, respectively. Only Bcc CF isolates accumulate within worms, an observation
that correlates well with the apparent differences in virulence factors between environmental
and CF isolates. This VR scheme was applied to profile Bcc pathogenesis in seven MRP
impaired C. elegansmutants. MRPs are implicated in distinct nematode cellular processes:
MRP1 is involved in heavy metal tolerance and ivermectine resistance [42,43]; MRP4 is central
in early-stage differentiation [55]; MRP5 acts as a fundamental heme exporter into embryonic
development [56]. Results showed increased nematode mortality for several C. elegansmutants
grown in the presence of specific Bcc strains compared to WT nematodes. In particularmrp-2
andmrp-5 were the most susceptible mutants with increased mortality respectively in 13 and
11 different Bcc strains in the two assays, suggesting an active role of these two efflux transport-
ers in host defense. However strain mpr-5 was tested only in heterozygosis and this could have
affected survival rate. Cluster analysis consistently grouped and separatedmrp-3 andmrp-4
mutants in both assays from the other MRP-phenotypes. This pattern suggested different sub-
strate specificity for these MRP transporters. To further explore the role of MRP transporters
in host defense, inhibitor experiments were carried out on a selected panel of the five most
"infectious" Bcc strains against the MRP knock-out mutants (B. ambifaria, B. arboris, B. cepa-
cia, B. dolosa, B. pyrrocinia). These strains were tested against the WT nematodes in the pres-
ence of three well-characterized MRP-inhibitors, with a broad inhibitory activity against MRP
transporters [51]. These results suggested that chemically disabling of the MRPs resulted in
increased C. elegans susceptibility to Bcc strains. The use of mometasone and lasalocid in the
infection system increased killing rate when incubated with B. cepacia and B. dolosa, while
verapamil showed a mild effect for B. arboris.
In conclusion, this study provided tools to correlate microbial pathogenicity with the host
transporters, and highlighted specific efflux systems with a central role in Bcc virulence.
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It is worth noting that MRPs share components of a conserved activation mechanism with
the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)[57,58]. Therefore, identifi-
cation of bacterial signalling molecules with substrate specificity in recognizing MRPs CFRT-
like efflux transporters involved in host response could be a starting point for the development
of novel therapeutic strategies.
Supporting Information
S1 Fig. Bcc strain growth in the presence of inhibitors. For the Bcc strain growth curves in
the presence of inhibitors, one single colony of each Bcc strain was placed in a tube containing
3 mL of LB broth. The tubes were then incubated at 37°C overnight in agitation. The overnight
cultures were used to inoculate 250 mL flasks containing 50 mL of LB broth plus the inhibitors
at an initial concentration of 0.01 OD600/mL. For each strain, a set of 5 flasks was employed:
1) Verapamile 100 μM; 2) Mometasone 100 μM; 3) Lasalocid 500 nM; 4) DMSO 0.5% v/v; 5)
control (no inhibitor or DMSO). The flasks were incubated at 37°C in agitation at 220 rpm.
Bacterial growth was monitored following OD600 for 36 hours every 2 hours. The experiments
were performed in duplicate and the data reported represent mean values. Error bars were
omitted for clarity. Results proved that the inhibitors did not interfere with Bcc growth at the
concentration used in our assays, as the growth curves obtained for each strain are very similar
with no viable effect in growth by any inhibitor.
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